Transposable elements as plasmid-based vectors for long-term gene transfer into tumors.

A primary limitation to using nonviral vectors for cancer gene therapy is transient expression of the therapeutic gene. Even when the ultimate goal is tumor cell death, a minimum threshold of gene expression is required to kill tumor cells by direct or indirect mechanisms. It has been shown that transposable elements can significantly enhance the duration of gene expression when plasmid DNA vectors are used to transfect tumor or tumor-associated stroma. Much like a retrovirus, transposon-based plasmid vectors achieve integration into the genome, and thereby sustain transgene expression, which is especially important in actively mitotic cells such as tumor cells. Herein we briefly discuss the different transposons available for gene therapy applications, and provide a detailed protocol for nonviral transposon-based gene delivery to solid experimental tumors in mice.

[1]  M. Kay,et al.  Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo , 2002, Nature Biotechnology.

[2]  D. Largaespada,et al.  Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies. , 2005, Current gene therapy.

[3]  Raghu Raghavan,et al.  Convection-enhanced delivery of therapeutics for brain disease, and its optimization. , 2006, Neurosurgical focus.

[4]  K. Lundstrom.  Latest development in viral vectors for gene therapy. , 2003, Trends in biotechnology.

[5]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[6]  Alfred L George,et al.  PiggyBac transposon-mediated gene transfer in human cells. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  D. F. Howard,et al.  Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Wei Chen,et al.  Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma , 2007, Cancer Gene Therapy.

[9]  D. Largaespada,et al.  Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  Shawn M. Burgess,et al.  High-Resolution Genome-Wide Mapping of Transposon Integration in Mammals , 2005, Molecular and Cellular Biology.

[11]  Craig J. Coates,et al.  piggyBac is a flexible and highly active transposon as compared to Sleeping Beauty, Tol2, and Mos1 in mammalian cells , 2006, Proceedings of the National Academy of Sciences.

[12]  R. Plasterk,et al.  The Frog Prince: a reconstructed transposon from Rana pipiens with high transpositional activity in vertebrate cells. , 2003, Nucleic acids research.

[13]  Mark A. Kay,et al.  Site-directed transposon integration in human cells , 2007, Nucleic acids research.

[14]  R. Plasterk,et al.  Molecular Reconstruction of Sleeping Beauty , a Tc1-like Transposon from Fish, and Its Transposition in Human Cells , 1997, Cell.

[15]  C. Coates,et al.  Chimeric Mos1 and piggyBac transposases result in site‐directed integration , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Z. Izsvák,et al.  Targeted Sleeping Beauty transposition in human cells. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  M. Mitreva,et al.  The bandit, a New DNA Transposon from a Hookworm—Possible Horizontal Genetic Transfer between Host and Parasite , 2007, PLoS neglected tropical diseases.

[18]  A. Hochberg,et al.  Regulatory sequences of H19 and IGF2 genes in DNA‐based therapy of colorectal rat liver metastases , 2005 .

[19]  Z. Izsvák,et al.  Transposons for gene therapy! , 2006, Current gene therapy.

[20]  F. Bushman.  Targeting Survival Integration Site Selection by Retroviruses and LTR-Retrotransposons , 2003, Cell.

[21]  Z. Izsvák,et al.  Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Daniel F Voytas,et al.  Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements. , 2002, Journal of molecular biology.

[23]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[24]  D. Largaespada,et al.  Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  P. Khavari,et al.  Stable nonviral genetic correction of inherited human skin disease , 2002, Nature Medicine.

[26]  M. Calos.  The phiC31 integrase system for gene therapy. , 2006, Current gene therapy.

[27]  M. Kay,et al.  Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. , 2006, Human gene therapy.

[28]  M. Kay,et al.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system , 2000, Nature Genetics.

[29]  X. Wang,et al.  Harnessing a High Cargo-Capacity Transposon for Genetic Applications in Vertebrates , 2006, PLoS genetics.

[30]  T. Jensen,et al.  390. Phage c31 Integrase Induces Chromosomal Aberrations in Primary Human Fibroblasts , 2006 .

[31]  Andrew Freese,et al.  Efficacy of nonviral gene transfer in the canine brain. , 2007, Journal of neurosurgery.

[32]  V. Pathak,et al.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Kay,et al.  Helper-independent Sleeping Beauty Transposon–transposase Vectors for Efficient Nonviral Gene Delivery and Persistent Gene Expression in Vivo , 2022 .

[34]  Zoltán Ivics,et al.  Sleeping beauty transposition: biology and applications for molecular therapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.